Drug details

Rethymic (allogeneic processed thymus tissue-agdc)

type of

Rethymic (allogeneic processed thymus tissue–agdc) is processed thymus tissue indicated for immune reconstitution in pediatric patients with congenital athymia. 

This drug may have the following side effects:
  • rash,
  • high blood pressure (hypertension),
  • cytokine release syndrome, 
  • low magnesium (hypomagnesemia), 
  • decreased kidney function/kidney failure,
  • low platelets (thrombocytopenia), and 
  • graft versus host disease.